BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26114485)

  • 21. The association of asthma and atrial fibrillation--a nationwide population-based nested case-control study.
    Chan WL; Yang KP; Chao TF; Huang CC; Huang PH; Chen YC; Chen TJ; Lin SJ; Chen JW; Leu HB
    Int J Cardiol; 2014 Sep; 176(2):464-9. PubMed ID: 25127961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shift Work: A Risk Factor for Central Serous Chorioretinopathy.
    Bousquet E; Dhundass M; Lehmann M; Rothschild PR; Bayon V; Leger D; Bergin C; Dirani A; Beydoun T; Behar-Cohen F
    Am J Ophthalmol; 2016 May; 165():23-8. PubMed ID: 26915576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between heart failure and central serous chorioretinopathy: A cohort study in Taiwan.
    Huang KH; Chen YH; Lee LC; Tai MC; Chung CH; Chen JT; Liang CM; Chien WC; Chen CL
    J Chin Med Assoc; 2019 Dec; 82(12):941-947. PubMed ID: 31805017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
    Hwang DK; Liu CJ; Pu CY; Chou YJ; Chou P
    JAMA Ophthalmol; 2014 Dec; 132(12):1446-52. PubMed ID: 25211300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis.
    Daruich A; Matet A; Dirani A; Bousquet E; Zhao M; Farman N; Jaisser F; Behar-Cohen F
    Prog Retin Eye Res; 2015 Sep; 48():82-118. PubMed ID: 26026923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.
    Kleinberger AJ; Patel C; Lieberman RM; Malkin BD
    Laryngoscope; 2011 Sep; 121(9):2034-7. PubMed ID: 22024860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central serous chorioretinopathy associated with topical corticosteroids in a patient with psoriasis.
    Ezra N; Taban M; Behroozan D
    J Drugs Dermatol; 2011 Aug; 10(8):918-21. PubMed ID: 21818516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of Systemic Risk Factors in Central Serous Chorioretinopathy.
    Islam QU; Hanif MK; Tareen S
    J Coll Physicians Surg Pak; 2016 Aug; 26(8):692-5. PubMed ID: 27539765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstructive sleep apnea and central serous chorioretinopathy.
    Brodie FL; Charlson ES; Aleman TS; Salvo RT; Gewaily DY; Lau MK; Farren ND; Engelhard SB; Pistilli M; Brucker AJ
    Retina; 2015 Feb; 35(2):238-43. PubMed ID: 25127049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of comorbid conditions between open-angle glaucoma patients and a control cohort: a case-control study.
    Lin HC; Chien CW; Hu CC; Ho JD
    Ophthalmology; 2010 Nov; 117(11):2088-95. PubMed ID: 20570357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled corticosteroids and the increased risk of pulmonary tuberculosis: a population-based case-control study.
    Chung WS; Chen YF; Hsu JC; Yang WT; Chen SC; Chiang JY
    Int J Clin Pract; 2014 Oct; 68(10):1193-9. PubMed ID: 24838040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A population-based study on the association between gastric ulcers and erectile dysfunction in Taiwan.
    Keller JJ; Lin HY; Chung SD; Lin HC
    J Sex Med; 2012 Mar; 9(3):686-93. PubMed ID: 22239977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corticosteroids and the risk of atrial fibrillation.
    van der Hooft CS; Heeringa J; Brusselle GG; Hofman A; Witteman JC; Kingma JH; Sturkenboom MC; Stricker BH
    Arch Intern Med; 2006 May; 166(9):1016-20. PubMed ID: 16682576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The adverse effects of corticosteroids in central serous chorioretinopathy.
    De Nijs E; Brabant P; De Laey JJ
    Bull Soc Belge Ophtalmol; 2003; (289):35-41. PubMed ID: 14619628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy.
    Miki A; Kondo N; Yanagisawa S; Bessho H; Honda S; Negi A
    Ophthalmology; 2014 May; 121(5):1067-72. PubMed ID: 24365176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands.
    van der Linden MW; Penning-van Beest FJ; Nijsten T; Herings RM
    Drug Saf; 2009; 32(6):527-37. PubMed ID: 19459719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.
    Nudleman E; Witmer MT; Kiss S; Williams GA; Wolfe JD
    Retina; 2014 Oct; 34(10):2128-32. PubMed ID: 24946102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased risk of co-morbid eye disease in patients with chronic renal failure: a population-based study.
    Wang TJ; Wu CK; Hu CC; Keller JJ; Lin HC
    Ophthalmic Epidemiol; 2012 Jun; 19(3):137-43. PubMed ID: 22568426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Profile of Central Serous Chorioretinopathy in an Indian Cohort.
    Sahoo NK; Singh SR; Kammari P; Jonnadula GB; Das AV; Chhablani J
    Nepal J Ophthalmol; 2019 Jan; 11(21):5-10. PubMed ID: 31523060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THE IMPORTANCE OF THE PERIPHERAL RETINA IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY.
    Oztas Z; Akkin C; Ismayilova N; Nalcaci S; Afrashi F
    Retina; 2018 Mar; 38(3):578-584. PubMed ID: 28234807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.